| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T218 |
0-294 |
Sentence |
denotes |
The goal would be that ACE2-Fc could treat infection in current patients preventing significant morbidities and death, while also serving as a potential prophylactic to give passive immunity to clinical providers on the frontlines, as well as individuals who may have been exposed to the virus. |
| T219 |
295-507 |
Sentence |
denotes |
Essentially, ACE2-Fc could be the potent neutralizing antibody that the global health community needs to combat 2019-nCoV, today, while also treating the underlying ARDS pathophysiology causing patient mortality. |
| T220 |
508-634 |
Sentence |
denotes |
It could be scaled much more quickly than convalescent patient sera, which would be dependent on infected individuals to make. |
| T221 |
635-791 |
Sentence |
denotes |
ACE2-Fc would be resistant to viral escape as well, unlike potential neutralizing monoclonal antibodies that may be developed in the coming weeks to months. |
